Burke Neurological Institute
Menu
Skip to main content
Our Team
Contact Us
Donate
Clinical Trials
Search form
Search
About Us
Conditions
Faculty / Research Labs & Core Facilities
News & Impact
Future Talent
Events
About Us
+
About the Institute
Our Mission & Vision
Our History
Our Leadership
Our Boards
Our Team
Affiliations & Partners
Funding Sources
Brand Toolkit
Research Compliance
Campus Guide
Contact Us
Conditions
+
Neurological Conditions
Stroke
Spinal Cord Injury
Traumatic Brain Injury
Cerebral Palsy
Neurodegenerative Diseases
Retinal Degenerative Diseases
Neurological Recovery
Motor Recovery
Pain & Sensory Recovery
Cognitive Recovery
Vision Recovery
Find a Clinical Trial
Inquire About Trials
Research Registry
Center for Pain & Sensory
Center for Vision Repair
Resilience Program
Campus Guide
Faculty / Research Labs & Core Facilities
+
Research Labs & Cores
Cho Lab
Friel Lab
Gibson Lab
Hussaini Lab
Hollis Lab
Marshel Lab
Prusky Lab
Ratan Lab
Sahni Lab
Travis Lab
Willis Lab
Yoshida Lab
Imaging Core
SCI Core
Research Methods
News & Impact
+
Recent News & Impact
News
Publications
Grants
Presentations
Future Talent
+
Programs & Opportunities
Open Job Positions
Summer Science
Intro to Neuroscience
NeuroAcademy
Postdoctoral Fellow
Graduate Medical Fellow
Undergraduate
High School
Events
+
Upcoming Events
Archived Events
Webinar Series
You are here
Home
>
Drug Discovery
Drug Discovery
Impact
Gibson Lab
PUBLICATION:
Journal Article
Calingasan NY, Gandy SE, Baker H, Sheu KF, Kim KS, Wisniewski HM, Gibson GE.
Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency.
Brain Res. 1995 Apr 17;677(1):50-60.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Aisen ML, Sevilla D, Gibson G, Kutt H, Blau A, Edelstein L, Hatch J, Blass J.
3,4-diaminopyridine as a treatment for amyotrophic lateral sclerosis.
J Neurol Sci. 1995 Mar;129(1):21-4.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Ito E, Oka K, Etcheberrigaray R, Nelson TJ, McPhie DL, Tofel-Grehl B, Gibson GE, Alkon DL.
Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease.
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):534-8.
Full-Text on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Huang HM, Toral-Barza L, Sheu KF, Gibson GE.
The role of cytosolic free calcium in the regulation of pyruvate dehydrogenase in synaptosomes.
Neurochem Res. 1994 Jan;19(1):89-95.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Etcheberrigaray R, Ito E, Oka K, Tofel-Grehl B, Gibson GE, Alkon DL.
Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease.
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8209-13.
Full-Text on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Huang HM, Gibson GE.
Altered beta-adrenergic receptor-stimulated cAMP formation in cultured skin fibroblasts from Alzheimer donors.
J Biol Chem. 1993 Jul 15;268(20):14616-21.
Abstract on PubMed
Prusky Lab
PUBLICATION:
Journal Article
Simon DK, Prusky GT, O'Leary DD, Constantine-Paton M.
N-methyl-D-aspartate receptor antagonists disrupt the formation of a mammalian neural map.
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10593-7.
Full-Text on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Carroll JM, Toral-Barza L, Gibson G.
Cytosolic free calcium and gene expression during chemical hypoxia.
J Neurochem. 1992 Nov;59(5):1836-43.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Gibson GE, Nielsen P, Toral-Barza L.
Synaptosomal plasma and mitochondrial membrane potentials during anoxia.
Neurosci Lett. 1992 Apr 13;138(1):133-6.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Review
Blass JP, Sheu KF, Cooper AJ, Jung EH, Gibson GE.
Thiamin and Alzheimer's disease.
J Nutr Sci Vitaminol (Tokyo). 1992;Spec No:401-4. Review.
Abstract on PubMed
« first
‹ previous
…
7
8
9
10
11
12
(current)
13
14
15
next ›
last »
Causes
Neurodegenerative Diseases
,
Stroke
,
Spinal Cord Injury
,
Retinal Degenerative Diseases
,
Cognitive Recovery
,
Vision Recovery